Navigation Links
Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs
Date:3/3/2008

e to:

- Equity holders of the Company (32,144) (24,696)

- Minority interests - -

Earnings per share for profit

attributable to the equity holders

of the Company during the year (0,69) (0,69)

Diluted earning per share (0,69) (0,69)

CONSOLIDATED BALANCE SHEET

Fiscal year ended December 31

2007 2006

(euro thousands)

ASSETS

Non-current assets

Property, plant & equipment 2,720 1,900

Intangible assets 464 214

Non-current financial instruments 14,402 -

Government subsidies receivable 5,264 1,521

Other financial assets 186 141

Deferred income tax assets 10 11

Total non-current assets 23,046 3,787

Current assets

Trade receivables 2,224 2,142

Government subsidies receivables 133 708

Other current assets 2,564 1,670

Prepaid expenses 3,083 1,362

Current financial instruments 14,967 27,602

Cash and cash equivalents 143,444 54,138

Total current assets 166,415 87,622

TOTAL ASSETS 189,461 91,409

EQUITY

Capital and Reserves attributable to

equity holders of the Company

Ordinary shares 9,457 7,610

Other reserves 159,757 66,
'/>"/>

SOURCE NicOx S.A.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
2. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
3. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
4. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
5. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
6. Progen Pharmaceuticals Announces Fiscal 2007 Financial Results
7. Biopure Announces 2007 Third Quarter Financial Results
8. Xytis Names Gordon H. Busenbark as Chief Financial Officer
9. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
10. Pharmacopeia Announces Third Quarter 2007 Financial Results
11. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Vivakor Announces New Acquisition Strategy 2St. Luke's Hospital Acquires Pioneering Technology From BrainLAB 2St. Luke's Hospital Acquires Pioneering Technology From BrainLAB 3Helix BioPharma Reports On 2009 Annual General Meeting 2Helix BioPharma Reports On 2009 Annual General Meeting 3New Shocking Documentary on Lyme Disease 26apos 3BUnder the Eightball 26apos 3B to Premiere at Michael Moore 26apos 3Bs State Theater in Traverse Cit 54938 1New Shocking Documentary on Lyme Disease 26apos 3BUnder the Eightball 26apos 3B to Premiere at Michael Moore 26apos 3Bs State Theater in Traverse Cit 54938 2Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 1Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 2Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 3Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 4Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 5Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 6President Obama Misleads on Abortion Funding in Health Care Reform 54931 1President Obama Misleads on Abortion Funding in Health Care Reform 54931 2